The University of Chicago Header Logo

Connection

Bruce Brockstein to Sirolimus

Back to Details
This is a "connection" page, showing publications Bruce Brockstein has written about Sirolimus.
Bruce Brockstein
Connection Strength
0.102
Sirolimus
  1. Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial. Lancet Oncol. 2013 Apr; 14(4):371-82.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.